Lantheus Weighs Potential $7 Billion Sale Following Offer From Curium
Lantheus Holdings, Inc · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES · Now $97.13
-3.3% in 3d after detection
Post-detection moves
1h
—
1d
-2.9%
3d
-3.3%
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS